Sionna Therapeutics(SION)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SION Sionna Therapeutics

盘前交易 06-04 05:27:48 EDT

36.70

+0.22

+0.60%

最高37.37	最低35.66	成交量31.93万
今开36.50	昨收36.48	日振幅4.69%
总市值16.51亿	流通市值5.79亿	总股本4,500万
成交额1,175万	换手率2.02%	流通股本1,578万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SION","market":"US","secType":"STK","nameCN":"Sionna Therapeutics","latestPrice":36.7,"timestamp":1780516800000,"preClose":36.48,"halted":0,"volume":319304,"delay":0,"changeRate":0.006030701754386129,"floatShares":15784300,"shares":44998073,"eps":-1.924665,"marketStatus":"盘前交易","change":0.22,"latestTime":"06-04 05:27:48 EDT","open":36.5,"high":37.37,"low":35.66,"amount":11749067,"amplitude":0.046875,"askPrice":58.67,"askSize":100,"bidPrice":35,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.924665,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780579800000},"marketStatusCode":1,"adr":0,"listingDate":1738904400000,"exchange":"NASDAQ","adjPreClose":36.7,"postHourTrading":{"tag":"盘后","latestPrice":36.7,"preClose":36.7,"latestTime":"16:10 EDT","volume":8,"amount":293.6,"timestamp":1780517405202,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7294089051938059,"impliedVol":1.7866,"impliedVolPercentile":0.8182},"requestUrl":"/m/hq/s/SION/tweets","defaultTab":"tweets","newsList":[{"id":"1138373042","title":"Sionna Therapeutics 维持2.899亿美元现金储备，预计运营资金可支撑至2028年","url":"https://stock-news.laohu8.com/highlight/detail?id=1138373042","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138373042?lang=zh_cn&edition=full","pubTime":"2026-05-12 19:24","pubTimestamp":1778585042,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics 公司宣布，其现金及现金等价物储备稳固保持在2.899亿美元。基于当前运营计划与财务预测，公司管理层预计，现有资金足以支持其各项研发及企业活动持续进行至2028年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150814177","title":"Sionna Therapeutics完成精准CF二期a阶段试验入组，评估Nbd1稳定剂Sion-719联合标准疗法对囊性纤维化患者疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1150814177","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150814177?lang=zh_cn&edition=full","pubTime":"2026-04-27 19:03","pubTimestamp":1777287782,"startTime":"0","endTime":"0","summary":"生物制药公司Sionna Therapeutics宣布，其针对囊性纤维化治疗的精准CF二期a阶段临床试验已完成患者入组。该试验重点评估在标准疗法基础上加用Nbd1稳定剂Sion-719的疗效与安全性。\n作为针对囊性纤维化根本病因的创新疗法，Sion-719通过稳定CFTR蛋白的Nbd1结构域发挥作用。此次试验采用精准医疗策略，旨在为特定患者群体探索更有效的治疗方案。\n临床试验的顺利推进标志着Sionna Therapeutics在呼吸系统疾病治疗领域取得重要进展。公司将持续关注试验数据，为后续研发决策提供科学依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101382332","title":"Sionna Therapeutics公司：现金及现金等价物约3.103亿美元，资金充裕，预计可支撑运营至2028年","url":"https://stock-news.laohu8.com/highlight/detail?id=1101382332","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101382332?lang=zh_cn&edition=full","pubTime":"2026-03-02 20:08","pubTimestamp":1772453332,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics公司宣布其财务状况稳健，目前持有约3.103亿美元的现金及现金等价物。这一充足的资金储备预计将支持公司持续运营至2028年，为未来的研发和业务拓展提供了坚实保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120365595","title":"2025年美股规模最大的IPO及其表现盘点：Anbio Biotechnology迄今涨幅最大","url":"https://stock-news.laohu8.com/highlight/detail?id=1120365595","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120365595?lang=zh_cn&edition=full","pubTime":"2025-12-19 11:27","pubTimestamp":1766114876,"startTime":"0","endTime":"0","summary":"此次发行正值 IPO 市场整体复苏之际。这使得 2025 年成为自 2021 年以来 IPO 表现最强劲的 12 个月周期，当年共有 401 家公司在美国证券交易所挂牌。Circle Internet Group稳定币发行商 Circle 的上市是今年规模最大的 IPO 之一。自六个月前开始在股市交易以来，Circle 的股价已上涨约 168%。Miami InternationalMiami International 于 8 月上市，募集资金 3.45 亿美元。自上市以来，Miami International 的股价累计上涨 88.5%。","market":"us","thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WSHP","ALM","NNNN","MENS","SION","CRCL","KRMN","MAZE","AUGO","MIAX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2517602818","title":"Sionna Therapeutics(SION.US)获Stifel首次覆盖，给予买入评级, 目标价32.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517602818","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517602818?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:42","pubTimestamp":1741110163,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics(SION.US)获Stifel首次覆盖，给予买入评级, 目标价32.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05014248524159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177801026","title":"异动解读 | Sionna Therapeutics盘中大涨38.89%,开盘即大涨33%创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1177801026","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177801026?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:02","pubTimestamp":1738951356,"startTime":"0","endTime":"0","summary":"生物技术公司Sionna Therapeutics今日盘中股价大涨38.89%,引发市场高度关注。\n\n公司今日在纳斯达克交易所成功 IPO,首次公开募股规模扩大至1.91亿美元,发行价为每股18美元。然而当日开盘后,Sionna Therapeutics的股价即飙升至24美元,较发行价飙升33%,充分体现了资本市场对公司的热捧。\n\n作为一家从事治疗囊性纤维化疾病药物研发的生物技术公司,Sionna Therapeutics正在与制药业巨头Vertex公司展开激烈竞争,力图在这一快速增长的市场占据一席之地。分析人士认为,Sionna成功 IPO体现了投资者对其长期前景的高度认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Sionna Therapeutics盘中大涨38.89%,开盘即大涨33%创新高","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sionnatx.com","stockEarnings":[{"period":"1week","weight":-0.155},{"period":"1month","weight":-0.0927},{"period":"3month","weight":0.0619},{"period":"6month","weight":-0.0891},{"period":"1year","weight":1.5345},{"period":"ytd","weight":-0.1079}],"compareEarnings":[{"period":"1week","weight":0.005},{"period":"1month","weight":0.0505},{"period":"3month","weight":0.107},{"period":"6month","weight":0.1},{"period":"1year","weight":0.2653},{"period":"ytd","weight":0.1061}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sionna Therapeutics, Inc.于2019年8月根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，其使命是通过开发使囊性纤维化跨膜电导调节蛋白功能正常化的新药，为CF患者提供具有临床意义的益处，从而彻底改变目前囊性纤维化患者的治疗模式。","exchange":"NASDAQ","name":"Sionna Therapeutics","nameEN":"Sionna Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sionna Therapeutics(SION)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sionna Therapeutics(SION)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sionna Therapeutics,SION,Sionna Therapeutics股票,Sionna Therapeutics股票老虎,Sionna Therapeutics股票老虎国际,Sionna Therapeutics行情,Sionna Therapeutics股票行情,Sionna Therapeutics股价,Sionna Therapeutics股市,Sionna Therapeutics股票价格,Sionna Therapeutics股票交易,Sionna Therapeutics股票购买,Sionna Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sionna Therapeutics(SION)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sionna Therapeutics(SION)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}